YU49279B - Postupak za pripremanje farmaceutske formulacije za dobijanje leka za inhalacionu primenu - Google Patents
Postupak za pripremanje farmaceutske formulacije za dobijanje leka za inhalacionu primenuInfo
- Publication number
- YU49279B YU49279B YU46095A YU46095A YU49279B YU 49279 B YU49279 B YU 49279B YU 46095 A YU46095 A YU 46095A YU 46095 A YU46095 A YU 46095A YU 49279 B YU49279 B YU 49279B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- inhalation
- pharmaceutical formulation
- procedure
- preparation
- mum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
Mešavina, naznačena time, što se jedno aktivno jedinjenje ili smeše aktivnih jedinjenja srednje veličine čestice 0.01 Вµm do 10 Вµm, pomeša sa laktozom koja se koristi u komercijalne svrhe kao ekscipijent a koja ima srednju veličinu čestica između 600 Вµm do 1000 Вµm. Prijava sadrži još dva nezavisna i devet zavisnih patentnih zahteva.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4425255A DE4425255A1 (de) | 1994-07-16 | 1994-07-16 | Formulierung zur inhalativen Applikation |
Publications (2)
Publication Number | Publication Date |
---|---|
YU46095A YU46095A (sh) | 1998-07-10 |
YU49279B true YU49279B (sh) | 2005-03-15 |
Family
ID=6523404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU46095A YU49279B (sh) | 1994-07-16 | 1995-07-11 | Postupak za pripremanje farmaceutske formulacije za dobijanje leka za inhalacionu primenu |
Country Status (32)
Country | Link |
---|---|
US (1) | US6284287B1 (sh) |
EP (1) | EP0771189B1 (sh) |
JP (1) | JP3011770B2 (sh) |
KR (1) | KR970704422A (sh) |
CN (1) | CN1234344C (sh) |
AT (1) | ATE204160T1 (sh) |
AU (1) | AU703924B2 (sh) |
BR (1) | BR9508287A (sh) |
CA (1) | CA2195065C (sh) |
CZ (1) | CZ290921B6 (sh) |
DE (2) | DE4425255A1 (sh) |
DK (1) | DK0771189T3 (sh) |
ES (1) | ES2162927T3 (sh) |
FI (1) | FI118790B (sh) |
HR (1) | HRP950403B1 (sh) |
HU (1) | HU223069B1 (sh) |
IL (1) | IL114596A (sh) |
IS (1) | IS1889B (sh) |
MX (1) | MX9700034A (sh) |
MY (1) | MY115688A (sh) |
NO (1) | NO315894B1 (sh) |
NZ (1) | NZ289117A (sh) |
PL (1) | PL186153B1 (sh) |
PT (1) | PT771189E (sh) |
RU (1) | RU2140260C1 (sh) |
SK (1) | SK282764B6 (sh) |
TR (1) | TR199500856A2 (sh) |
TW (1) | TW475904B (sh) |
UA (1) | UA29507C2 (sh) |
WO (1) | WO1996002231A1 (sh) |
YU (1) | YU49279B (sh) |
ZA (1) | ZA955892B (sh) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9700133D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
EP0876814A1 (en) * | 1997-05-07 | 1998-11-11 | "PHARLYSE", Société Anonyme | Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it |
IT1309592B1 (it) | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
ITMI991582A1 (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
AU7685200A (en) * | 1999-10-12 | 2001-04-23 | Kaken Pharmaceutical Co., Ltd. | Powdery inhalational preparations and process for producing the same |
GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
GB0009469D0 (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
DE60128902T2 (de) * | 2000-04-17 | 2008-02-14 | Vectura Ltd., Chippenham | Formulierungen zur verwendung in inhalationsvorrichtungen |
GB0009468D0 (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formulations for use in inhaler devices |
PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
UA72014C2 (en) | 2000-10-12 | 2005-01-17 | Boehringer Ingelheim Pharma | Tiotropium-containing powdery preparations for inhalations intended for treating asthma and chronic obstructive pulmonary disease (variants), method for their production and capsule |
UA75375C2 (en) * | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
US20020151541A1 (en) * | 2000-10-31 | 2002-10-17 | Michel Pairet | Pharmaceutical compositions containing tiotropium salts and antihistamines and their use |
US7776315B2 (en) * | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
US20100310477A1 (en) * | 2000-11-28 | 2010-12-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg. | Pharmaceutical compositions based on anticholingerics and additional active ingredients |
US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
DE10141377A1 (de) * | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Aufstreuverfahren zur Herstellung von Pulverformulierungen |
DE10141376A1 (de) * | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Inhalationspulvern |
US6702997B2 (en) | 2001-10-26 | 2004-03-09 | Dey, L.P. | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
US20030203930A1 (en) * | 2001-10-26 | 2003-10-30 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
JP2003221335A (ja) | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
US20030191151A1 (en) * | 2001-10-26 | 2003-10-09 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
US20030140920A1 (en) * | 2001-10-26 | 2003-07-31 | Dey L.P. | Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma |
US7754242B2 (en) * | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
LT1531794T (lt) * | 2002-06-28 | 2017-08-25 | Civitas Therapeutics, Inc. | Inhaliuojamas epinefrinas |
GB0219511D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
EP1599209B1 (en) * | 2002-08-21 | 2011-08-17 | Norton Healthcare Limited | Inhalation composition |
US20050158248A1 (en) * | 2002-08-21 | 2005-07-21 | Xian-Ming Zeng | Method of preparing dry powder inhalation compositions |
US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
DE10255387A1 (de) * | 2002-11-28 | 2004-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Tiotropium-haltige Pulverformulierung für die Inhalation |
US7763280B2 (en) * | 2002-11-28 | 2010-07-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation |
ATE510174T1 (de) | 2003-05-21 | 2011-06-15 | Alexza Pharmaceuticals Inc | Schlag gezündete unabhängige heizeinheit |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
BRPI0509348A (pt) | 2004-04-21 | 2007-09-11 | Innovata Biomed Ltd | inalador |
GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
GB0613161D0 (en) * | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
EP1925295A1 (de) * | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stabile Pulverformulierung enthaltend ein Anticholinergikum |
EP1944018A1 (en) * | 2007-01-10 | 2008-07-16 | CHIESI FARMACEUTICI S.p.A. | Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
KR20150041804A (ko) | 2007-02-11 | 2015-04-17 | 맵 파마슈티컬스, 인코포레이티드 | 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 dhe의 치료적 투여 방법 |
ES2594867T3 (es) | 2007-03-09 | 2016-12-23 | Alexza Pharmaceuticals, Inc. | Unidad de calentamiento para usar en un dispositivo de administración de fármaco |
US20100272811A1 (en) * | 2008-07-23 | 2010-10-28 | Alkermes,Inc. | Complex of trospium and pharmaceutical compositions thereof |
CA2732585A1 (en) * | 2008-07-30 | 2010-02-04 | Stc.Unm | Formulations containing large-size carrier particles for dry powder inhalation aerosols |
US9572863B2 (en) | 2011-12-13 | 2017-02-21 | Pieris Pharmaceuticals Gmbh | Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors |
JP6231022B2 (ja) * | 2012-02-28 | 2017-11-15 | アイシューティカ ホールディングス インク.Iceutica Holdings Inc. | 吸入可能な医薬組成物 |
PT3175842T (pt) | 2015-12-03 | 2020-03-04 | Tiefenbacher Alfred E Gmbh & Co Kg | Processo de mistura de pó seco |
CA3150240A1 (en) | 2019-09-24 | 2021-04-01 | Tomaso GUIDI | Dry powder formulation for a dry powder inhaler, with a combination of spheronised particles and coarse particles, and a dry powder inhaler comprising the formulation |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3860618A (en) | 1967-08-08 | 1975-01-14 | Philip Saxton Hartley | Chromone |
GB1242211A (en) | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
US3957965A (en) | 1967-08-08 | 1976-05-18 | Fisons Limited | Sodium chromoglycate inhalation medicament |
GB1381872A (en) * | 1971-06-22 | 1975-01-29 | Fisons Ltd | Pharmaceutical compositions for inhalation |
GB1410588A (en) | 1971-08-10 | 1975-10-22 | Fisons Ltd | Composition |
GB1520247A (en) | 1974-08-10 | 1978-08-02 | Fisons Ltd | Pelletised medicament formulations |
DE2535258C2 (de) * | 1974-08-10 | 1993-06-03 | Fisons Plc, Ipswich, Suffolk | Inhalierbares Medikament in Pelletform |
GB1520248A (en) | 1975-07-24 | 1978-08-02 | Fisons Ltd | Sodium cromoglycate containing medicament |
US4161516A (en) | 1975-07-25 | 1979-07-17 | Fisons Limited | Composition for treating airway disease |
IL51233A (en) | 1975-07-28 | 1980-07-31 | Fisons Ltd | Pharmaceutical compositions in the form of soft pellets or granules |
IL57956A (en) | 1975-07-28 | 1980-07-31 | Fisons Ltd | Disodium cromoglycate in pellet or granule form having a low loose bulk density |
AU522792B2 (en) | 1977-07-19 | 1982-06-24 | Fisons Plc | Pressure pack formulation |
GB1571629A (en) * | 1977-11-30 | 1980-07-16 | Fisons Ltd | Pharmaceutical compositions containing beclomethasone dipropionate |
CY1333A (en) * | 1980-04-30 | 1986-10-24 | Fisons Ltd | Pharmaceutical compositions containing cromoglycates |
IT1204826B (it) | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
US5376386A (en) | 1990-01-24 | 1994-12-27 | British Technology Group Limited | Aerosol carriers |
GB9001635D0 (en) * | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
WO1991011174A1 (en) * | 1990-01-25 | 1991-08-08 | The University Of Colorado Foundation, Inc. | Method for preventing immune suppression in trauma patients |
GB9027968D0 (en) * | 1990-12-22 | 1991-02-13 | Fisons Plc | Method of treatment |
DE4140689B4 (de) | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalationspulver und Verfahren zu ihrer Herstellung |
US5658549A (en) * | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
TW244350B (sh) | 1991-12-14 | 1995-04-01 | Hoechst Ag | |
WO1993025198A1 (en) | 1992-06-12 | 1993-12-23 | Teijin Limited | Ultrafine powder for inhalation and production thereof |
IS1736B (is) | 1993-10-01 | 1999-12-30 | Astra Ab | Aðferð og tæki sem stuðla að aukinni samloðun agna |
GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
-
1994
- 1994-07-16 DE DE4425255A patent/DE4425255A1/de not_active Withdrawn
-
1995
- 1995-06-21 JP JP8504624A patent/JP3011770B2/ja not_active Expired - Fee Related
- 1995-06-21 UA UA97020661A patent/UA29507C2/uk unknown
- 1995-06-21 PL PL95318649A patent/PL186153B1/pl not_active IP Right Cessation
- 1995-06-21 US US08/765,928 patent/US6284287B1/en not_active Expired - Fee Related
- 1995-06-21 MX MX9700034A patent/MX9700034A/es not_active IP Right Cessation
- 1995-06-21 NZ NZ289117A patent/NZ289117A/en not_active IP Right Cessation
- 1995-06-21 WO PCT/EP1995/002392 patent/WO1996002231A1/de active IP Right Grant
- 1995-06-21 CA CA002195065A patent/CA2195065C/en not_active Expired - Fee Related
- 1995-06-21 KR KR1019970700209A patent/KR970704422A/ko not_active Application Discontinuation
- 1995-06-21 SK SK56-97A patent/SK282764B6/sk not_active IP Right Cessation
- 1995-06-21 HU HU9700131A patent/HU223069B1/hu not_active IP Right Cessation
- 1995-06-21 AU AU28862/95A patent/AU703924B2/en not_active Ceased
- 1995-06-21 DK DK95924299T patent/DK0771189T3/da active
- 1995-06-21 DE DE59509518T patent/DE59509518D1/de not_active Expired - Lifetime
- 1995-06-21 CZ CZ1997126A patent/CZ290921B6/cs not_active IP Right Cessation
- 1995-06-21 CN CNB95194066XA patent/CN1234344C/zh not_active Expired - Fee Related
- 1995-06-21 RU RU97102349A patent/RU2140260C1/ru not_active IP Right Cessation
- 1995-06-21 AT AT95924299T patent/ATE204160T1/de not_active IP Right Cessation
- 1995-06-21 BR BR9508287A patent/BR9508287A/pt active Search and Examination
- 1995-06-21 EP EP95924299A patent/EP0771189B1/de not_active Expired - Lifetime
- 1995-06-21 ES ES95924299T patent/ES2162927T3/es not_active Expired - Lifetime
- 1995-06-21 PT PT95924299T patent/PT771189E/pt unknown
- 1995-06-30 TW TW084106804A patent/TW475904B/zh active
- 1995-07-11 YU YU46095A patent/YU49279B/sh unknown
- 1995-07-14 HR HR950403A patent/HRP950403B1/xx not_active IP Right Cessation
- 1995-07-14 IL IL11459695A patent/IL114596A/xx not_active IP Right Cessation
- 1995-07-14 TR TR95/00856A patent/TR199500856A2/xx unknown
- 1995-07-14 ZA ZA955892A patent/ZA955892B/xx unknown
- 1995-07-17 MY MYPI95002021A patent/MY115688A/en unknown
-
1996
- 1996-12-13 IS IS4396A patent/IS1889B/is unknown
-
1997
- 1997-01-08 NO NO19970068A patent/NO315894B1/no not_active IP Right Cessation
- 1997-01-15 FI FI970164A patent/FI118790B/fi active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU49279B (sh) | Postupak za pripremanje farmaceutske formulacije za dobijanje leka za inhalacionu primenu | |
AU7921887A (en) | Therapeutic agents | |
CA2628857A1 (en) | Formulation and method for treating neoplasms by inhalation | |
CA2024916A1 (en) | Respiratory disorder medicaments comprising salmeterol and fluticasone propionate | |
CA2258095A1 (en) | Tetrahydrolipstatin containing compositions | |
ES2116918A1 (es) | Medicamento para la administracion nasal. | |
CA2093806A1 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
AU2001236207A1 (en) | Powder formulation | |
GEP20043314B (en) | Pharmaceutical Composition Comprising Entacapone, Levodopa, and Carbidopa | |
CA2240329A1 (en) | Improved delivery of multiple doses of medications | |
AU644094B2 (en) | Medicaments | |
MY124465A (en) | Reduction of infarct volume using citicoline | |
AU3318389A (en) | Azelastine-containing medicaments with controlled release of the active substance | |
BE2016C017I2 (sh) | ||
CA2255856A1 (en) | Therapeutic uses for an aminosterol compound | |
EP0367509A3 (en) | Formulations | |
ECSP961835A (es) | Nuevo procedimiento | |
SE8304818D0 (sv) | A medicine having anti-ulcer, spasmolytic and locally anesthetic effect | |
MY111155A (en) | Medicaments | |
IT1262929B (it) | Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici | |
MX9802026A (es) | Formulaciones farmaceuticas que contienen darifenacina. |